July 20, 2021
Showing 21 - 30 of 116 results
Stronger Shields for Seniors: Respiratory Protection with High-Dose Flu and Recombinant Protein non-mRNA COVID Vaccine Strategies
This webinar will explore evidence-based approaches to protecting respiratory health in LTC settings, with a focus on high dose influenza vaccine and a recombinant protein, non-mRNA COVID-19 vaccine option. Sanofi’s medical directors, Dr. Morgan Anderson and Dr. Katie Sharff, will share insights on the latest influenza vaccine pooled analysis FLUNITY-HD and discuss evolving data on the recombinant protein, non-mRNA COVID-19 vaccine. They will be joined by Dr. Chad Worz, CEO of the American Society of Consultant Pharmacists (ASCP), to provide expert perspectives on clinical implications and practical applications for elder care.
Read MoreFebruary 15, 2019
Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A/H1N1-Predominant Influenza Season
Influenza is a leading cause of admissions for nursing home (NH) residents. We previously evaluated the effectiveness of a high-dose trivalent influenza vaccine (HD) compared to a standard-dose influenza vaccine (SD) through a cluster-randomized trial of NH residents. Fewer residents from facilities rando...May 30, 2025
Which Enhanced Influenza Vaccine Has the Greatest Immunogenicity in Long-Term Care Residents: The Adjuvanted or the High-Dose Formulation?
This study compares enhanced influenza vaccines recommended for older adults, adjuvanted flu vaccine (aTIV, FLUAD) vs high-dose flu vaccine (HD-IIV3, FLUZONE HD) to determine if they met noninferiority standards for older long-term care facility (LTCF) residents.March 20, 2021
“Somebody Like Me”: Understanding COVID-19 Vaccine Hesitancy among Staff in Skilled Nursing Facilities
The vaccination of skilled nursing facility (SNF) staff is a critical component in the battle against COVID-19. Together, residents and staff constitute the single most vulnerable population in the pandemic. The health of these workers is completely entangled with the health of those they care for. Vaccina...January 6, 2023
Evidence on the Effects of the Federal COVID-19 Vaccine Mandate on Nursing Home Staffing Levels
To assess the federal COVID-19 vaccine mandate's effects on nursing homes' nurse aide and licensed nurse staffing levels in states both with and without state-level vaccine mandates.June 7, 2023
Association of Sources of COVID-19 Information with Vaccine Uptake, Preventive Behaviors, and Perceived Severity of COVID-19
To investigate the association of using informal sources and reliance on multiple sources of information with actual COVID-19 vaccine uptake, the number of doses of vaccine received, COVID-19 testing, essential preventive measures, and perceived severity of COVID-19.Vaccine Preventable Respiratory Infections in the Long Term Care Setting
This webinar will review select respiratory vaccines that are recommended for patients in the LTC channel. The content will be tailored for patients in LTC, focusing on risk, BOD, and strategies for overcoming vaccine hesitancy. This session was developed by Pfizer. It is part of the PALTmed | Industry Insights Presents series and is provided for informational purposes only. PALTmed does not endorse or sponsor the content.
February 23, 2022
Strong Decay of SARS-CoV-2 Spike Antibodies after 2 BNT162b2 Vaccine Doses and High Antibody Response to a Third Dose in Nursing Home Residents
To measure the antibody decay after 2 BNT162b2 doses and the antibody response after a third vaccine dose administered 6 months after the second one in nursing home residents with and without prior COVID-19.September 4, 2024